Publications
- Trial watch: Peptide-based vaccines in anticancer therapy2018 | Second Faculty of Medicine
- Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death2015 | Second Faculty of Medicine
- Trial watch: Dendritic cell-based anticancer therapy2014 | Second Faculty of Medicine
- Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy2014 | Second Faculty of Medicine
- Trial Watch Dendritic cell-based interventions for cancer therapy2013 | Second Faculty of Medicine
- Type I interferon and cancer2024 | Second Faculty of Medicine
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma2023 | First Faculty of Medicine, Second Faculty of Medicine
- Trial watch: chemotherapy-induced immunogenic cell death in oncology2023 | Second Faculty of Medicine
- Interferon signaling restrains renal cell carcinoma heterogeneity2023 | Second Faculty of Medicine
Loading network view...